Edition:
United Kingdom

HBM Healthcare Investments AG (HBMN.S)

HBMN.S on Swiss Exchange

165.60CHF
22 Mar 2019
Change (% chg)

CHF0.20 (+0.12%)
Prev Close
CHF165.40
Open
CHF166.80
Day's High
CHF167.40
Day's Low
CHF165.40
Volume
2,393
Avg. Vol
6,083
52-wk High
CHF184.80
52-wk Low
CHF139.40

Chart for

About

HBM Healthcare Investments AG is a Switzerland-based venture capital company investing in emerging companies, mainly from the biotechnology and human medicine, diagnostics, as well as medical technology sectors. The Company focuses on unlisted companies, with two-thirds of assets being invested in private companies that offer... (more)

Overall

Beta: 0.49
Market Cap(Mil.): CHF838.46
Shares Outstanding(Mil.): 7.04
Dividend: 5.80
Yield (%): 4.87

Financials

  HBMN.S Industry Sector
P/E (TTM): 10.87 87.16 19.21
EPS (TTM): 10.95 -- --
ROI: 8.26 6.52 0.46
ROE: 9.11 12.15 15.44

BRIEF-HBM Healthcare Investments 9-mth Profit Of CHF 81 Million

* PROFIT OF CHF 81 MILLION FOR FIRST NINE MONTHS OF 2018/2019 FINANCIAL YEAR

25 Jan 2019

BRIEF-HBM Healthcare Investments 9M Net Profit Of Around CHF 81 Million Versus CHF 85.6 Million Year Ago

* 9M NET PROFIT OF AROUND CHF 81 MILLION VERSUS CHF 85.6 MILLION YEAR AGO

03 Jan 2019

BRIEF-HBM Healthcare Investments H1 Net Earnings At CHF 177 Mln

* PROFIT OF CHF 110.4 MILLION IN Q2 OF 2018/2019 FINANCIAL YEAR Source text for Eikon: Further company coverage: (Gdynia Newsroom)

25 Oct 2018

BRIEF-HBM Healthcare Investments: Successful IPO Of Y-Mabs Therapeutics

* SUCCESSFUL IPO OF Y-MABS THERAPEUTICS INCREASES NET ASSET VALUE PER HBM-SHARE BY CHF 4.82 (+2.7%) Source text for Eikon: Further company coverage: (Gdynia Newsroom)

24 Sep 2018

Earnings vs. Estimates